Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)
Status: | Active, not recruiting |
---|---|
Conditions: | Infectious Disease, Hematology, Hematology, Hematology |
Therapuetic Areas: | Hematology, Immunology / Infectious Diseases |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 6/29/2018 |
Start Date: | July 2014 |
End Date: | March 2020 |
A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura
The purpose of this study is to determine whether fostamatinib is safe and effective in
treating patients with persistent/chronic Immune Thrombocytopenic Purpura (ITP) over a 5 year
period.
treating patients with persistent/chronic Immune Thrombocytopenic Purpura (ITP) over a 5 year
period.
Inclusion Criteria:
- Completed week 24 evaluation of Study C935788-047 or Study C935788-048 or discontinued
early due to lack of response.
- Able and willing to give written informed consent
Exclusion Criteria:
- Discontinued participation in Study C935788-047 or Study C935788-048 for any reason
other than lack of response
- Poorly controlled hypertension during Study C935788-047 or Study C935788-048
- Significant infection, an acute infection such as influenza, or known inflammatory
process
We found this trial at
10
sites
Peoria, Illinois 61614
Principal Investigator: Michael Tarantino, MD
Phone: 309-692-5337
Click here to add this to my saved trials
6410 Rockledge Dr #660
Bethesda, Maryland 20817
Bethesda, Maryland 20817
(301) 571-0019
Principal Investigator: Ralph Boccia, MD
Phone: 240-482-0526
Center for Cancer & Blood Disorders Widely recognized for its compassionate, expert care, the Center...
Click here to add this to my saved trials
Concord, New South Wales
Principal Investigator: Ilona Cunningham, MD
Phone: 2 9767-5757
Click here to add this to my saved trials
Click here to add this to my saved trials
Lafayette, Indiana
Principal Investigator: Wael Harb, MD
Phone: 765-446-5165
Click here to add this to my saved trials
Middletown, Ohio 45042
Principal Investigator: Nandagopal Vrindavanam, MD
Phone: 513-423-0504
Click here to add this to my saved trials
New York, New York 10021
Principal Investigator: James Bussel, MD
Phone: 212-746-3474
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Tucson, Arizona 85745
Principal Investigator: Michael Boxer, MD
Phone: 520-866-0206
Click here to add this to my saved trials